- Home
- VYGR vs COE Comparison
VYGR vs COE Comparison
Compare VYGR & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- COE
- Stock Information
- Founded
- VYGR 2013
- COE 2011
- Country
- VYGR United States
- COE Singapore
- Employees
- VYGR N/A
- COE N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- COE Other Consumer Services
- Sector
- VYGR Health Care
- COE Real Estate
- Exchange
- VYGR Nasdaq
- COE Nasdaq
- Market Cap
- VYGR 206.9M
- COE 177.0M
- IPO Year
- VYGR 2015
- COE 2016
- Fundamental
- Price
- VYGR $4.24
- COE $47.37
- Analyst Decision
- VYGR Strong Buy
- COE
- Analyst Count
- VYGR 7
- COE 0
- Target Price
- VYGR $14.50
- COE N/A
- AVG Volume (30 Days)
- VYGR 678.8K
- COE 19.7K
- Earning Date
- VYGR 08-06-2025
- COE 09-03-2025
- Dividend Yield
- VYGR N/A
- COE N/A
- EPS Growth
- VYGR N/A
- COE N/A
- EPS
- VYGR N/A
- COE N/A
- Revenue
- VYGR $42,580,000.00
- COE $68,928,000.00
- Revenue This Year
- VYGR N/A
- COE N/A
- Revenue Next Year
- VYGR $107.07
- COE N/A
- P/E Ratio
- VYGR N/A
- COE N/A
- Revenue Growth
- VYGR N/A
- COE 93.05
- 52 Week Low
- VYGR $2.65
- COE $12.98
- 52 Week High
- VYGR $8.28
- COE $48.25
- Technical
- Relative Strength Index (RSI)
- VYGR 70.98
- COE 84.75
- Support Level
- VYGR $3.32
- COE $33.38
- Resistance Level
- VYGR $3.49
- COE $36.99
- Average True Range (ATR)
- VYGR 0.23
- COE 2.43
- MACD
- VYGR 0.06
- COE 1.10
- Stochastic Oscillator
- VYGR 94.03
- COE 94.65
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.